CBD

United States: Sunil Aggarwal, PhD – Removal of Cannabis from Schedule I of the Controlled Substances Act

The Pharmaceuticalization of Cannabis: Rescheduling proponents suggest cannabis doesn't meet the Controlled Substances Act's extensive criteria for placement in Schedule I. The U.S. Government clings to the stance that cannabis merit’s Schedule I status.

By Michael Bachara, Hemp News Correspondent

United States: Sunil Aggarwal – The Pharmaceuticalization of Cannabis Sunil Aggarwal, PhD, represents a new generation of scientific-minded doctors, leaving cannabis’ negative propaganda behind and fighting for it as a valuable, medicinal plant. His credentials include the Medical and Scientific Advisory Board of Americans for Safe Access (ASA), Health Professionals for Responsible Drug Scheduling, service on the Board of Directors for the American Academy of Cannabinoid Medicine and he is a Seattle Hempfest Core Staff Member.

Research: CBD and Cancer - Cannabidiol Treatment For Cancer

Part 2 in Storm Crow's look at the little known but highly effective medical ingredients in cannabis.

By Storm Crow, Salem-News.com

There is a truth that must be heard! (NORTHERN Calif.) - There is a lot more to cannabis than just THC. Although the press and science have focused on THC because of its effects on the brain, the other cannabinoids are potent medicines in their own right. Studies reveal that CBD, a non-psychoactive cannabinoid, may affect cancer cells of many types. Breast cancer, leukemia and glioma (a rather nasty brain cancer) are all slowed, or even killed by CBD.

I usually put in something amusing into my articles, but I find nothing amusing about cancer. Both of my grandmothers died of it. So please forgive me if I do not amuse you this time, but "cut straight to the chase".

In 2006, a study called "Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma," (see: Breast cancer: Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma) compared the effect of five different compounds found in cannabis on an aggressive breast cancer. CBD was the clear winner.

Syndicate content